Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 04/07/2011 14640_de.jpg

    The adhesion of cells to the endothelium and to artificial surfaces

    Professor Stefan W. Schneider from the Mannheim Medical Faculty is investigating the function of the vascular endothelium and its interaction with blood and tumour cells using microfluidics methods that enable him to measure the adhesion of cells to the walls of blood vessels under physiological flow conditions. As part of an interdisciplinary project, he is investigating the characteristics of wafer-thin surfaces covered with living cells, which…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-adhesion-of-cells-to-the-endothelium-and-to-artificial-surfaces
  • Article - 18/04/2011 09570_de.jpg

    Can tissue be glued together in a non-invasive way?

    At present, the use of substances to glue tissue together is only an idea, but it might eventually mean that surgeons will no longer need to use a needle and thread. The cellular and molecular biologist Rainer Wittig from the Ulm-based ILM hopes to develop such substances using a photochemical process. He is also planning to test substances that not only adhere to tissue but which will also be able to initiate the wound healing process.

    https://www.gesundheitsindustrie-bw.de/en/article/news/can-tissue-be-glued-together-in-a-non-invasive-way
  • Press release - 21/03/2011 Protection: The microscope photos show that much fewer bacteria colonise coated (photo on the left, fewer green spots) rather than uncoated sections of implants (a larger number of green spots).<br />

    Polymer brushes with mini proteins protect implants

    Patients who have had surgical implants are at risk of developing serious complications due to bacterial infections. This affects around two to six per cent of patients with implants. Scientists from the KIT Institute of Functional Interfaces (IFG) have now succeeded in developing a protective layer that prevents bacteria from adhering to implants and creating dangerous biofilms that can lead to serious infections. The protective layer has proven…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/polymer-brushes-with-mini-proteins-protect-implants
  • Article - 21/03/2011 13935_de.jpg

    Fluoron – a company that is well underway

    Fluoron is a company that takes close contact with customers very seriously. This is why Christian Lingenfelder and his team frequently pack their suitcases to travel from place to place visiting Russian or Chinese operating theatres. Thousands of kilometres from the company’s production site in Ulm, the Fluoron team exchanges information with the retina surgeons for whom the company develops and produces highly pure biomaterials for use in…

    https://www.gesundheitsindustrie-bw.de/en/article/news/fluoron-a-company-that-is-well-underway
  • Press release - 13/03/2011 13874_de.jpg

    Vascular stent that dissolves on its own

    The first ever implant in Germany of a bioresorbable, drug-coated stent in a cardiac patient has been carried out by physicians from the University of Heidelberg. In contrast to traditional metal stents, which remain permanently in the patients’ body, the innovative implant dissolves around two years after the procedure is carried out.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/vascular-stent-that-dissolves-on-its-own
  • Article - 06/12/2010 An Asian in a dark suit presenting data.

    Bioplastics – materials that have the potential to be used in medical technology

    At the recent International Symposium on Biopolymers ISBP in Stuttgart scientists discussed the use of biobased plastics for applications in the field of medical technology. The majority of strategies presented at the symposium will only be ready for market in a few years time. However they give an idea as to why bioplastics are likely to be applied to a greater extent in the field of medical technology.

    https://www.gesundheitsindustrie-bw.de/en/article/news/bioplastics-materials-that-have-the-potential-to-be-used-in-medical-technology
  • Article - 09/08/2010 The BALL software can combine different presentations. The Figure shows the surface (solvent-excluded surface, SES) of a molecule, combined with a sphere-rod model and the van der Waals model. A clipping plane was used to get a better look at the two ligands. <br />

    Computer-assisted drug design

    Bioinformaticians from Tübingen have developed the “BALL” software platform that accelerates and simplifies the search for active agents. Computer modelling and simulation enables the assessment of molecule modifications and the optimisation of their function accordingly.

    https://www.gesundheitsindustrie-bw.de/en/article/news/computer-assisted-drug-design
  • Article - 12/06/2010 Technician in front of a microscope, looking at the results on a computer screen.<br />

    Reliable evidence of efficacy using skin models and assays

    In the molecular biology laboratory at the Albstadt-Sigmaringen University of Applied Sciences a team led by Prof. Dr. Jörg Bergemann is developing and optimising assays that enable the quantitative determination of DNA damage and the investigation of repair mechanisms. The researchers exclusively use in vitro test systems. Using tissue engineering methods the researchers are developing a skin model for pharmacological efficacy and…

    https://www.gesundheitsindustrie-bw.de/en/article/news/reliable-evidence-of-efficacy-using-skin-models-and-assays
  • Press release - 25/01/2010 10566_de.jpg

    Amedrix GmbH - New investment paves the way for own production operations

    The High-Tech Gründerfonds (HTGF) and Life Science Fonds Esslingen are jointly investing a total of 700,000 EUR in Amedrix GmbH, which was founded in January 2009. The Esslingen-based company develops innovative, acellular medical products based on animal collagen for wound regeneration and the reconstruction of degenerated soft tissue, for example. The new investment means that necessary steps can be taken to gain approval for first medical…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/amedrix-gmbh-new-investment-paves-the-way-for-own-production-operations
  • Press release - 08/01/2009 The figure shows two photos, both of them have a dark red background and light red spots; the right sides of the two photos is twice as light as the left side.<br />

    ILM – Bioactive interfaces

    It is particularly important to consider the biocompatibility of material interfaces. For example, implant materials with a surface composition that favours cell growth have a decisive advantage. However there are other cases where biophobic material characteristics might be more suitable. For example, specifically modifying the surface of surgical metals might prevent pathogens from attaching and could also make the cleaning and deactivation of…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-bioactive-interfaces
  • Press release - 24/11/2008

    Schölly Fibre Optics in Denzlingen – at the limit of production capacities

    Schölly Fiberoptic GmbH based in the city of Denzlingen in the south of Germany has experienced rapid growth over the last few years with its endoscopic solutions. Over the last five years the company has doubled its revenues to 44 million euros per year.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/schoelly-fibre-optics-in-denzlingen-at-the-limit-of-production-capacities
  • Press release - 20/02/2008

    ZRM and Naturin develop innovative biomembranes

    The Centre for Regenerative Biology and Medicine ZRM in Tübingen has joined forces with Naturin GmbH based in Weinheim. The partners plan to develop new carrier materials on the basis of collagen which improve cell cultures and medical implants.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/zrm-and-naturin-develop-innovative-biomembranes
  • Press release - 21/01/2008

    Micro-biolytics GmbH - Top spectroscopy technology for the pharmaceutical industry

    Micro-biolytics GmbH now based in the Esslingen-based Life Science Centre develops and produces microsystems solutions for bioanalytical issues. With the support of networks micro-biolytics is hoping to considerably expand its activities.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/micro-biolytics-gmbh-top-spectroscopy-technology-for-the-pharmaceutical-industry

Page 2 / 2

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • 2
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search